Get started
INCYTE CORPORATION COM USD0.001INCYTE CORPORATION COM USD0.001INCYTE CORPORATION COM USD0.001

INCYTE CORPORATION COM USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0J9P chart


Full chart

0J9P upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪15.71 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
588.80
Basic EPS (TTM)
0.16 USD
Net income (FY)
‪597.60 M‬ USD
Revenue (FY)
‪3.70 B‬ USD
Shares float
‪190.30 M‬
Beta (1Y)
0.75

Employees


Employees (FY)
‪2.52 K‬
Change (1Y)
+200 +8.61%
Revenue / Employee (1Y)
‪1.46 M‬ USD
Net income / Employee (1Y)
‪236.77 K‬ USD

About Incyte Corporation


Sector
Health Technology
CEO
Herve Hoppenot
Headquarters
Wilmington
Website
incyte.com
Founded
1991
FIGI
BBG00JRY8N23
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0J9P news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where 0J9P is featured.

See all sparks 

Frequently Asked Questions


The current price of 0J9P is 80.68 USD — it has decreased by −0.85% in the past 24 hours. Watch INCYTE CORPORATION COM USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange INCYTE CORPORATION COM USD0.001 stocks are traded under the ticker 0J9P.
0J9P stock has risen by 7.38% compared to the previous week, the month change is a 24.15% rise, over the last year INCYTE CORPORATION COM USD0.001 has showed a 54.10% increase.
We've gathered analysts' opinions on INCYTE CORPORATION COM USD0.001 future price: according to them, 0J9P price has a max estimate of 97.00 USD and a min estimate of 52.00 USD. Watch 0J9P chart and read a more detailed INCYTE CORPORATION COM USD0.001 stock forecast: see what analysts think of INCYTE CORPORATION COM USD0.001 and suggest that you do with its stocks.
0J9P reached its all-time high on Jul 21, 2020 with the price of 108.92 USD, and its all-time low was 50.02 USD and was reached on Apr 30, 2024. View more price dynamics on 0J9P chart.
See other stocks reaching their highest and lowest prices.
0J9P stock is 1.90% volatile and has beta coefficient of 0.75. Track INCYTE CORPORATION COM USD0.001 stock price on the chart and check out the list of the most volatile stocks — is INCYTE CORPORATION COM USD0.001 there?
Today INCYTE CORPORATION COM USD0.001 has the market capitalization of ‪15.71 B‬, it has increased by 10.07% over the last week.
Yes, you can track INCYTE CORPORATION COM USD0.001 financials in yearly and quarterly reports right on TradingView.
INCYTE CORPORATION COM USD0.001 is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
0J9P earnings for the last quarter are 1.07 USD per share, whereas the estimation was 1.05 USD resulting in a 1.79% surprise. The estimated earnings for the next quarter are 1.50 USD per share. See more details about INCYTE CORPORATION COM USD0.001 earnings.
INCYTE CORPORATION COM USD0.001 revenue for the last quarter amounts to ‪1.14 B‬ USD, despite the estimated figure of ‪1.08 B‬ USD. In the next quarter, revenue is expected to reach ‪1.14 B‬ USD.
0J9P net income for the last quarter is ‪106.46 M‬ USD, while the quarter before that showed ‪−444.60 M‬ USD of net income which accounts for 123.94% change. Track more INCYTE CORPORATION COM USD0.001 financial stats to get the full picture.
No, 0J9P doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 12, 2024, the company has ‪2.52 K‬ employees. See our rating of the largest employees — is INCYTE CORPORATION COM USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INCYTE CORPORATION COM USD0.001 EBITDA is ‪76.18 M‬ USD, and current EBITDA margin is 19.87%. See more stats in INCYTE CORPORATION COM USD0.001 financial statements.
Like other stocks, 0J9P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INCYTE CORPORATION COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INCYTE CORPORATION COM USD0.001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INCYTE CORPORATION COM USD0.001 stock shows the strong buy signal. See more of INCYTE CORPORATION COM USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.